LONGOBARDI, CIRO
 Distribuzione geografica
Continente #
NA - Nord America 379
EU - Europa 302
AS - Asia 169
AF - Africa 24
OC - Oceania 1
Totale 875
Nazione #
US - Stati Uniti d'America 376
GB - Regno Unito 93
CN - Cina 64
SE - Svezia 54
DE - Germania 40
SG - Singapore 40
VN - Vietnam 29
IT - Italia 27
IN - India 22
CH - Svizzera 16
IE - Irlanda 16
RU - Federazione Russa 14
TG - Togo 14
FI - Finlandia 9
FR - Francia 9
JO - Giordania 9
ZA - Sudafrica 9
UA - Ucraina 6
BG - Bulgaria 5
BE - Belgio 4
EE - Estonia 4
CA - Canada 3
ID - Indonesia 2
AU - Australia 1
HK - Hong Kong 1
IR - Iran 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
NG - Nigeria 1
NL - Olanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 875
Città #
Southend 87
Chandler 52
Santa Clara 46
Singapore 35
Dong Ket 29
Ashburn 28
Princeton 25
Fairfield 18
Ann Arbor 16
Dublin 16
Bern 15
Houston 15
Lomé 14
Wilmington 14
New York 13
Boardman 10
Amman 9
Cambridge 9
Helsinki 9
Westminster 9
Medford 8
Padova 8
Nanjing 7
Pune 7
Shenyang 7
Bologna 6
Hebei 6
Mülheim 6
Woodbridge 6
Berlin 5
Saint Petersburg 5
Sofia 5
Tianjin 5
Brussels 4
Dearborn 4
Jinan 4
Seattle 4
Beijing 3
Changsha 3
Toronto 3
Florence 2
Guangzhou 2
Jiaxing 2
London 2
Mountain View 2
Norwalk 2
Pekanbaru 2
Redwood City 2
Wuhan 2
Abeokuta 1
Ardabil 1
Bratislava 1
Canyon 1
Chengdu 1
Chongqing 1
City of Westminster 1
Council Bluffs 1
Den Haag 1
Haikou 1
Hefei 1
Humble 1
Jieyang 1
Jinhua 1
Kuban 1
Kunming 1
Langfang 1
Lausanne 1
Melbourne 1
Mesagne 1
Nanchang 1
Orange 1
Phoenix 1
San Diego 1
Shanghai 1
Stockholm 1
Taizhou 1
Vijayawada 1
Weihai 1
Xian 1
Totale 623
Nome #
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 147
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 116
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 111
Second-line chemotherapy in biliary tract cancer patients. 96
Second-line chemotherapy in patients with biliary tract cancer. 93
The follow-up issues: from the necessity to the opportunity 90
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. 85
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study 79
Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma. 76
Totale 893
Categoria #
all - tutte 2.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.183


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 0 0 14 13 6 4 8 16
2020/202186 20 2 1 2 0 4 1 3 11 1 2 39
2021/2022146 9 11 4 4 16 10 6 6 5 7 36 32
2022/2023243 32 42 19 22 13 16 3 15 37 9 19 16
2023/202472 8 10 1 3 4 30 7 1 2 2 4 0
2024/2025141 13 30 14 18 58 8 0 0 0 0 0 0
Totale 893